03.01.2022 · Based on the Journal Feedback System, the avarage publication fees of British Journal of Pharmacology are around 0.5 USD. To publish in British Journal of Pharmacology with Open Access Lincense, authors are required to pay an overall article publishing charges (APC) : $ 0.5 USD. User Experiences When did you submit your manuscript? 2021
Jan 03, 2022 · Based on the Journal Feedback System, the avarage publication fees of British Journal of Pharmacology are around 0.5 USD. To publish in British Journal of Pharmacology with Open Access Lincense, authors are required to pay an overall article publishing charges (APC) : $0.5 USD.
If authors opt to publish via the open access route, submissions will be subject to an APC if accepted and published in the journal: $4,200 USD/ £3,000 GBP/ €3,600 EUR. Authors who receive funding from an agency or institution with a Wiley Open Access Account do not pay directly. The charge is paid by the institution or funder.
If authors opt to publish via the open access route, submissions will be subject to an APC if accepted and published in the journal: $4,200 USD/ £3,000 GBP/ € ...
An official journal of the British Pharmacological Society. Speed Fast high-quality peer review decision times: - 22 days on average to first decision, and 13 days for fast-tracked papers - 10 days on average for peer reviewers to complete review reports Fast publishing times – 45 days to Early View, 3 days to Accepted Article. Scope
Jun 01, 2006 · The British Journal of Pharmacology (BJP) has started accepting open-access articles, subject to payment of a publication fee. The journal is moving to a mixed-revenue model of subscription charges and publication fees. For the remainder of 2006, the publication fee will be $2,500, €e1,850 or £1,250 + VAT (where applicable).
In the year 2017 and 2019, the journal had the highest impact factor of journals in the category "Pharmacology and Pharmacy" when excluding journals that ...
Article Publication Charges. BJP offers authors the chance to publish their articles open access: immediately freely available to read, download and share. If authors opt to publish via the open access route, submissions will be subject to an APC if accepted and published in the journal: $4,200 USD/ £3,000 GBP/ €3,600 EUR.
23.12.2021 · Based on the Journal Feedback System, the avarage publication fees of British Journal of Clinical Pharmacology are around - USD. To publish in British Journal of Clinical Pharmacology with Open Access Lincense, authors are required to pay an overall article publishing charges (APC) : $ - USD. User Experiences
The set of journals have been ranked according to their SJR and divided into four ... The two years line is equivalent to journal impact factor ™ (Thomson ...
Please note that the journal no longer accepts submission of Rapid Communications and Short Communications. Submission checklist. You can use this list to carry ...
For NIH-funded authors, manuscripts are deposited in PubMed to be made publicly available 12 months after publication. Wiley offers an optional Online Open ...
The British Journal of Pharmacology is the leading international general pharmacology journal published by the British Pharmacological Society. It publishes high-quality original research and authoritative reviews, addresses topical pharmacology issues, and is committed to transparency and scientific rigor.
Publishing articles. Writing for academic journals can be very competitive, but is a fantastic way to share your research. Find out more about publishing ...
Submit to British Journal of Pharmacology. An official journal of the British Pharmacological Society. Speed. Fast high-quality peer review decision times: - 22 days on average to first decision, and 13 days for fast-tracked papers - 10 days on average for peer reviewers to complete review reports
The British Journal of Pharmacology is the leading international general pharmacology journal published by the British Pharmacological Society. It publishes high-quality original research and authoritative reviews, addresses topical pharmacology issues, and is committed to transparency and scientific rigor.